- -

Pharmaceutical Cost Analysis of Diabetes Mellitus Using Clinical Risk Groups in Valencian Community

RiuNet: Institutional repository of the Polithecnic University of Valencia

Share/Send to

Cited by

Statistics

Pharmaceutical Cost Analysis of Diabetes Mellitus Using Clinical Risk Groups in Valencian Community

Show full item record

Romero; M.; Usó Talamantes, R.; Vivas Consuelo, DJJ.; Poza Plaza, EDL.; Sancho Mestre, C.; Trillo Mata, JL.; Barrachina Martínez, I. (2013). Pharmaceutical Cost Analysis of Diabetes Mellitus Using Clinical Risk Groups in Valencian Community. Value in Health. 16(7):691-691. doi:10.1016/j.jval.2013.08.2067

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10251/62810

Files in this item

Item Metadata

Title: Pharmaceutical Cost Analysis of Diabetes Mellitus Using Clinical Risk Groups in Valencian Community
Author:
UPV Unit: Universitat Politècnica de València. Departamento de Economía y Ciencias Sociales - Departament d'Economia i Ciències Socials
Issued date:
Abstract:
Metabolic agents have the highest expense (130 million Euros per year in the Valencian Community) among the top five therapeutic categories of drugs for adults aged 18 and over. Treatment of Diabetes Mellitus (DM) is the ...[+]
Copyrigths: Cerrado
Source:
Value in Health. (issn: 1098-3015 ) (eissn: 1524-4733 )
DOI: 10.1016/j.jval.2013.08.2067
Publisher:
Elsevier
Publisher version: http://dx.doi.org/10.1016/j.jval.2013.08.2067
Type: Artículo

This item appears in the following Collection(s)

Show full item record